drugset / Trial / NCT05134792

Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients

NCT05134792

Phase 2/3 Completed 30 enrolled Cairo University
RandomizedParallel-groupDouble-blindPrevention

Summary

Effect of pre-emptive intravenous immunoglobulin administration on the incidence of septic episodes in pediatric burn patients: A randomized controlled study.

Timeline

Start
2021-10-10
Primary completion
2022-07-16
Completion
2022-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Immune Globulin Intravenous (Human) Protein / enzyme biologic 200 mg/kg Intravenous

Indications

No indication recorded.